Vectura confirms launch of Seebri Neohaler in the 1 234 567

Vectura confirms launch of Seebri Neohaler in the

livecharts.co.uk

FTSE 250 inhaler maker Vectura said on Thursday that Sunovion, the US licensee of the group's partner Novartis, has launched the twice-daily long acting muscarinic inhibitor Seebri Neohaler in the US.

Full news

Share:

More:

1 234 567

1 234 567

1 234 567

1 234 567

1 234 567

1 234 567